ロード中...
Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections
Imipenem/cilastatin/relebactam (Recarbrio™) is an intravenously administered combination of the carbapenem imipenem, the renal dehydropeptidase-I inhibitor cilastatin, and the novel β-lactamase inhibitor relebactam. Relebactam is a potent inhibitor of class A and class C β-lactamases, conferring imi...
保存先:
| 出版年: | Drugs |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7905759/ https://ncbi.nlm.nih.gov/pubmed/33630278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-021-01471-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|